MARKET

SUPN

SUPN

Supernus Pharma
NASDAQ
53.87
-0.40
-0.74%
After Hours: 53.87 0 0.00% 17:24 03/06 EST
OPEN
53.43
PREV CLOSE
54.27
HIGH
54.24
LOW
52.27
VOLUME
649.63K
TURNOVER
--
52 WEEK HIGH
59.68
52 WEEK LOW
29.16
MARKET CAP
3.10B
P/E (TTM)
-78.8842
1D
5D
1M
3M
1Y
5Y
1D
Supernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
TipRanks · 3d ago
Supernus Pharmaceuticals Balances Record Sales With Rising Costs
TipRanks · 4d ago
Weekly Report: what happened at SUPN last week (0223-0227)?
Weekly Report · 5d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oxford BioMedica (OtherOXBDF), Valneva (VALN) and Supernus Pharmaceuticals (SUPN)
TipRanks · 02/27 08:10
Analysts Conflicted on These Healthcare Names: Valneva (VALN) and Supernus Pharmaceuticals (SUPN)
TipRanks · 02/27 08:00
Supernus Pharmaceuticals (SUPN) Receives a Hold from Stifel Nicolaus
TipRanks · 02/25 15:57
Supernus price target raised to $65 from $60 at TD Cowen
TipRanks · 02/25 12:47
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 02/25 12:05
More
About SUPN
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company’s diverse neuroscience portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson’s disease (PD) patients receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea. It is also developing a range of product candidates for CNS disorders. Its commercial products that it markets include Qelbree, GOCOVRI, Oxtellar XR, Trokendi XR, APOKYN, XADAGO, MYOBLOC and ONAPGO. Its ONAPGO injection is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced PD. It also offers ZURZUVAE (zuranolone) capsules CIV, which is a U.S. FDA-approved oral medicine indicated for the treatment of adults with postpartum depression.

Webull offers Supernus Pharmaceuticals Inc stock information, including NASDAQ: SUPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SUPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SUPN stock methods without spending real money on the virtual paper trading platform.